GLP-1 Weight Loss Treatments Online

GLP-1 medications are prescription treatments that mimic the glucagon-like peptide-1 hormone your gut releases after eating. They reduce appetite, slow stomach emptying, and support blood sugar control, which together help many people lose weight when combined with diet and activity. Semaglutide and tirzepatide are the two most widely used.

There is no single best option for everyone. In branded trials tirzepatide produced larger average weight reduction, while semaglutide has the longest track record and, in its branded Wegovy form, a proven cardiovascular benefit. A licensed provider recommends the option that fits your health history and goals.

Semaglutide activates GLP-1 receptors. Tirzepatide activates both GIP and GLP-1 receptors, and in head-to-head branded research produced larger average weight reduction. Both are once-weekly injectables in their branded forms and are also offered here as compounded and oral options.

Brand-name products such as Wegovy, Ozempic, Zepbound, and Mounjaro are FDA-approved and manufactured by their makers. Compounded GLP-1s are prepared by licensed compounding pharmacies and are not FDA-approved and not established as equivalent to the branded products, but often cost substantially less. A provider can explain the trade-offs.

Yes. Compounded oral semaglutide and oral tirzepatide are daily, needle-free options for people who prefer to avoid injections. A provider can explain differences in absorption and dosing versus the weekly injectables.

In branded trials, weekly semaglutide produced about 15% average body-weight reduction over 68 weeks, and tirzepatide about 20-21% over 72 weeks, in both cases alongside lifestyle changes. Individual results vary, and compounded preparations were not part of those trials.

Yes. Every GLP-1 treatment on DripVitals requires a valid prescription issued by a licensed provider after an online review. None are available over the counter.

DripVitals plans are cash-pay and do not bill insurance. Some commercial plans cover brand-name GLP-1s for eligible patients, and manufacturers offer savings programs — checking your benefits before deciding how to fill a prescription is worthwhile.

Nausea, diarrhea, constipation, vomiting, and stomach discomfort are the most common, especially during dose changes, and usually ease over time. Each product page has a detailed safety section, and GLP-1s carry a boxed warning regarding thyroid C-cell tumors.

Complete a short online health questionnaire, get reviewed by a licensed provider, and if approved your medication ships from a licensed pharmacy. You can also check your BMI first to see where you stand.

FDA-approved GLP-1 medications (Wegovy, Ozempic, Zepbound, Mounjaro) are reviewed by the FDA for safety, effectiveness, and quality for their approved uses. Compounded GLP-1 medications are prepared by licensed compounding pharmacies to fill individual prescriptions and are not reviewed or approved by the FDA before dispensing. They typically cost substantially less, but are not established as equivalent to the branded products.

No. Compounded semaglutide and compounded tirzepatide are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. A licensed provider determines whether a compounded medication is appropriate for your individual medical needs.

The FDA has received reports of dosing errors with compounded injectable semaglutide, often related to drawing up doses from vials with syringes or confusing units and milliliters. To reduce risk, follow your provider’s written dosing instructions exactly, use only the supplies provided, never adjust your dose on your own, and ask your provider or pharmacist before injecting if anything is unclear.

Eligibility is determined by a licensed provider based on your full health picture. Branded weight-management products like Wegovy and Zepbound are FDA-approved for adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition. Checking your BMI takes under a minute and helps frame the conversation, but the provider makes the final call.

Tell both your GLP-1 provider and your surgical or anesthesia team that you take a GLP-1 medication before any surgery, procedure, general anesthesia, or deep sedation. Because GLP-1s slow stomach emptying, they have been associated with rare reports of pulmonary aspiration during procedures under general anesthesia or deep sedation, and your care team may adjust timing or give special fasting instructions.

Sometimes, with provider guidance. People switch for reasons like plateaued progress, side effects, or cost, and a licensed provider determines whether a switch is appropriate, what the equivalent starting dose should be, and how to transition safely. Never switch or combine GLP-1 medications on your own.